MCTM 5366: Idea to Clinic II -- Into the Clinic

The course will cover Clinical trials: Phase 0 through IV; utilizing special regulatory considerations as: Regenerative Medicine; Biomarkers; In Vitro Diagnostics; Contrast Agents. The students will learn about funding strategies for clinical trials and begin work on a new model: The Translational Research Initiative. This type of study will enhance the students' strategic perspectives on clinical trials from the point of view of the academic, major corporate, and biotech spin-off worlds. Students will learn about the profiles of key personnel roles in all phases of the Idea-to-Clinic transition; as well as the options for entrepreneurship and leadership in translational management.